E1	Condition:T1 Name:T2 Acuteness:T76
E3	Condition:T3 Name:T4 Acuteness:T75
E5	Condition:T5 Name:T6
E7	Condition:T7 Name:T8 Stability:T77
E9	Condition:T9 Name:T10
E14	Condition:T14 Name:T15
E16	Procedure:T16 Name:T17 Stability:T103
E18	Condition:T18 Name:T19
E20	Condition:T20 Name:T21
E22	Condition:T22 Name:T23 Severity:T95
E24	Condition:T24 Name:T25
E29	Condition:T29 Name:T30
E33	Age:T40 Numeric-Filter:E35
E35	Eq-Comparison:T46 Operator:T34 Temporal-Unit:T37 Value:T42
E36	Eq-Comparison:T47 Operator:T35 Value:T44 Unit:T31 Per:T108 Per2:T109
E37	Eq-Comparison:T48 Operator:T36 Temporal-Unit:T39 Value:T45 Temporal-Period:T110
E38	Eq-Comparison:T49 Temporal-Period:T50
E39	Eq-Comparison:T51 Temporal-Period:T52
E40	Eq-Comparison:T53 Temporal-Period:T54
E4	Observation:T41 Name:T57 Stability:T59
E6	Modifier:T58 Modifies:T57
E8	Modifier:T60 Modifies:T57
E10	Assertion:T61 Asserted:E8
E11	Eq-Comparison:T11 Temporal-Period:T12
E13	Procedure:T63 Name:T64 Temporality:E11
E15	Observation:T65 Name:T71
E17	Modifier:T66 Modifies:T64
E19	Modifier:T67 Modifies:T64
E21	Modifier:T68 Modifies:T71
E23	Negation:T69 Negates:E17
E25	Negation:T70 Negates:E19
E27	Modifier:T72 
E28	Assertion:T73 Asserted:E27
E34	Modifier:T79 Modifies:T6
E41	Negation:T80 Negates:E34
E42	Other:T81 Is-Other:E9
E26	Procedure:T26 Name:T27
E44	Modifier:T83 Modifies:T27
E45	Assertion:T84 Asserted:E26
E46	Condition:T28 Name:T85
E47	Procedure:T86 Name:T87 Temporality:E40
E48	Condition:T88 Temporality:E38
E49	Procedure:T89 Temporality:E39 Temporality2:E50
E50	Eq-Comparison:T90 Temporal-Period:T91 Value:T43 Temporal-Unit:T38
E51	Allergy:T92 Severity:T93 Name:T94
E52	Drug:T96 Name:T97
E53	Drug:T98 Name:T99
E55	Study:T101 
E56	Assertion:T102 Asserted:E55
E57	Assertion:T104 Asserted:T103
E59	Observation:T106 Name:T107 Numeric-Filter:E36 Temporality:E37
E60	Condition:T111 Name:T112
E32	Observation:T32 Name:T33
E61	Assertion:T113 Asserted:E32
T1	Condition 270 291	myocardial infarction
T2	Condition-Name 270 291	myocardial infarction
T3	Condition 235 252	coronary syndrome
T4	Condition-Name 235 252	coronary syndrome
T5	Condition 331 345	cardiomyopathy
T6	Condition-Name 331 345	cardiomyopathy
T7	Condition 304 310	angina
T8	Condition-Name 304 310	angina
T9	Condition 355 370	cardiac disease
T10	Condition-Name 355 370	cardiac disease
T13	Life-Stage-And-Gender 25 28	Men
T14	Condition 377 398	mitral valve prolapse
T15	Condition-Name 377 398	mitral valve prolapse
T16	Procedure 700 713	premedication
T17	Procedure-Name 700 713	premedication
T18	Condition 776 789	Renal failure
T19	Condition-Name 776 789	Renal failure
T20	Condition 793 804	dysfunction
T21	Condition-Name 793 804	dysfunction
T22	Condition 664 673	urticaria
T23	Condition-Name 664 673	urticaria
T24	Condition 886 895	Pregnancy
T25	Condition-Name 886 895	Pregnancy
T29	Condition 562 565	CAD
T30	Condition-Name 562 565	CAD
T34	Eq-Operator 43 44	≥
T35	Eq-Operator 842 843	<
T36	Eq-Operator 855 861	within
T37	Eq-Temporal-Unit 48 53	years
T38	Eq-Temporal-Unit 581 587	months
T39	Eq-Temporal-Unit 873 879	months
T40	Age 39 42	age
T42	Eq-Value 45 47	40
T43	Eq-Value 578 580	12
T44	Eq-Value 843 845	30
T45	Eq-Value 871 872	3
T46	Eq-Comparison 43 53	≥ 40 years
T47	Eq-Comparison 842 854	<30ml/min/m2
T48	Eq-Comparison 855 879	within the past 3 months
T49	Eq-Comparison 501 508	current
T50	Eq-Temporal-Period 501 508	current
T51	Eq-Comparison 534 544	Previously
T52	Eq-Temporal-Period 534 544	Previously
T53	Eq-Comparison 472 477	Prior
T54	Eq-Temporal-Period 472 477	Prior
T55	Life-Stage-And-Gender 33 38	women
T41	Observation 79 83	pain
T57	Observation-Name 79 83	pain
T58	Modifier 73 78	chest
T59	Stability 66 72	Stable
T60	Modifier 87 97	equivalent
T61	Assertion 98 106	symptoms
T11	Eq-Comparison 112 119	Planned
T12	Eq-Temporal-Period 112 119	Planned
T63	Procedure 145 152	testing
T64	Procedure-Name 145 152	testing
T65	Observation 176 180	pain
T66	Modifier 136 144	invasive
T67	Modifier 124 130	urgent
T68	Modifier 170 175	chest
T69	Negation 132 135	non
T70	Negation 120 123	non
T71	Observation-Name 176 180	pain
T72	Modifier 184 194	equivalent
T73	Assertion 195 203	symptoms
T75	Acuteness 229 234	Acute
T76	Acuteness 264 269	acute
T77	Stability 295 303	unstable
T79	Modifier 322 330	ischemic
T80	Negation 318 321	non
T81	Other 349 354	other
T26	Procedure 433 451	cardiac evaluation
T27	Procedure-Name 433 451	cardiac evaluation
T83	Modifier 426 432	urgent
T84	Assertion 412 417	would
T28	Condition 463 466	CAD
T85	Condition-Name 463 466	CAD
T86	Procedure 478 496	cardiac evaluation
T87	Procedure-Name 478 496	cardiac evaluation
T88	Condition 520 528	symptoms
T89	Procedure 545 557	investigated
T90	Eq-Comparison 573 587	last 12 months
T91	Eq-Temporal-Period 573 577	last
T92	Allergy 600 608	allergic
T93	Severity 593 599	Severe
T94	Allergy-Name 621 639	iodinated contrast
T95	Severity 641 645	mild
T96	Drug 719 727	Benadryl
T97	Drug-Name 719 727	Benadryl
T98	Drug 730 740	Prednisone
T99	Drug-Name 730 740	Prednisone
T101	Study 764 769	study
T102	Assertion 741 744	may
T103	Stability 686 696	controlled
T104	Assertion 679 682	can
T106	Observation 806 842	estimated Glomerular Filtration Rate
T107	Observation-Name 806 842	estimated Glomerular Filtration Rate
T31	Eq-Unit 845 847	ml
T108	Eq-Temporal-Unit 848 851	min
T109	Eq-Unit 852 854	m2
T110	Eq-Temporal-Period 866 870	past
T111	Condition 936 949	premenopausal
T112	Condition-Name 936 949	premenopausal
T32	Observation 1016 1036	pregnancy strip test
T33	Observation-Name 1016 1036	pregnancy strip test
T113	Assertion 982 989	will be
A1	Eq-Operator-Value T34 GTEQ
A2	Eq-Operator-Value T35 LT
A3	Eq-Operator-Value T36 LTEQ
A4	Eq-Temporal-Unit-Value T37 year
A5	Eq-Temporal-Unit-Value T38 month
A6	Eq-Temporal-Unit-Value T39 month
A7	Eq-Temporal-Period-Value T50 present
A8	Eq-Temporal-Period-Value T52 past
A9	Eq-Temporal-Period-Value T54 past
A10	Life-Stage-And-Gender-Type T13 male
A11	Life-Stage-And-Gender-Type T55 female
A12	Stability-Value T59 stable
A13	Assertion-Type-Value E10 possible
A14	Eq-Temporal-Period-Value T12 future
A15	Assertion-Type-Value E28 possible
A18	Stability-Value T77 change
A19	Assertion-Type-Value E45 hypothetical
A20	Eq-Temporal-Period-Value T91 past
A21	Severity-Value T93 severe
A22	Severity-Value T95 mild
A23	Assertion-Type-Value E56 hypothetical
A24	Stability-Value T103 stable
A25	Assertion-Type-Value E57 hypothetical
A26	Observation-Type-Value E59 lab
A27	Eq-Temporal-Unit-Value T108 minute
A28	Eq-Temporal-Period-Value T110 past
A29	Observation-Type-Value E32 lab
A30	Assertion-Type-Value E61 hypothetical
A31	Acuteness-Type-Value T75 acute
A32	Acuteness-Type-Value T76 acute
R1	Treatment-For Arg1:E13 Arg2:E15
R2	Example-Of Arg1:E1 Arg2:E3
R3	Example-Of Arg1:E7 Arg2:E3
R4	Example-Of Arg1:E5 Arg2:E3
R5	Example-Of Arg1:E9 Arg2:E3
R6	Example-Of Arg1:E14 Arg2:E9
R7	Treatment-For Arg1:E26 Arg2:E9
R8	Treatment-For Arg1:E47 Arg2:E48
R9	Treatment-For Arg1:E49 Arg2:E29
R10	Using Arg1:E16 Arg2:E52
R11	Using Arg1:E16 Arg2:E53
R12	Treatment-For Arg1:E16 Arg2:E22
R13	Caused-By Arg1:E22 Arg2:E51
R14	Equivalent-To Arg1:E59 Arg2:E20
R15	If-Then Arg1:E60 Arg2:E32
R16	Or Arg1:T13 Arg2:T55
R17	Or Arg1:E4 Arg2:E8
R18	Or Arg1:E15 Arg2:E27
R19	Or Arg1:E1 Arg2:E7
R20	Or Arg1:E5 Arg2:E9
R21	Or Arg1:E52 Arg2:E53
R22	Or Arg1:E18 Arg2:E20
